Publication
Article
Marcia S. Brose, MD, PhD
Director of Cancer Services
Sidney Kimmel Cancer Center
Thomas Jefferson University Hospitals
Philadelphia, PA
Josh J. Carlson, PhD, MPH
Associate Professor
CHOICE Institute, School of Pharmacy
University of Washington
Seattle, WA
Noah Federman, MD
Clinical Professor
Director, Pediatric Bone and Soft Tissue
Sarcoma Program
David Geffen School of Medicine
University of California, Los Angeles
Los Angeles, CA
Antoine Italiano, MD, PhD
Professor
Early Phase Trials and Sarcoma Units
Institut Bergonié
Bordeaux, France
Shivaani Kummar, MD, FACP
DeArmond Endowed Chair of Cancer Research
Professor and Head, Division of Hematology and
Medical Oncology
Codirector, Center for Experimental Therapeutics
Knight Cancer Institute
Oregon Health and Science University
Portland, OR
Ulrik Lassen, MD, PhD
Professor of Clinical Oncology
Department of Oncology
Rigshospitalet
Copenhagen, Denmark
Sean D. Sullivan, PhD, MSc, RPh
Dean and Professor of Pharmacy
School of Pharmacy
Hutchinson Institute for Cancer
Outcomes Research
Fred Hutchinson Cancer Research Center
University of Washington
Seattle, WA
These faculty have disclosed the following relevant commercial financial relationships or affiliations in the past 12 months.
Marcia S. Brose, MD, PhD
CONSULTANCIES OR PAID ADVISORY BOARDS
AstraZeneca, Bayer, Eli Lilly and Company,
Genentech, Loxo Oncology
HONORARIA
Clinical Care Options, Medscape,
OncLive®, PeerView
INSTITUTIONAL CONFLICTS OF INTEREST
Research support to the University of
Pennsylvania School of Pharmacy from
Bayer, Blueprint Medicines, Eisai, Eli Lilly and
Company, Genentech, Loxo Oncology, Novartis
Josh J. Carlson, PhD, MPH
CONSULTANCIES OR PAID ADVISORY BOARDS
Bayer
HONORARIA
Adaptive Biotechnologies
Noah Federman, MD
CONSULTANTIES OR PAID ADVISORY BOARDS
Bayer, Loxo Oncology
GRANTS RECEIVED
Research is supported by NIH National Center
for Advancing Translational Science (NCATS)
UCLA Clinical & Translational Science Institute
(CTSI) Grant Number UL1TR001881
LECTURE FEES FOR SPEAKING AT THE
INVITATION OF A COMMERCIAL SPONSOR
Bayer
ROYALTIES
NanoValent Pharmaceuticals, Inc
STOCK OWNERSHIP
Stock held in for-profit health care companies
bluebird bio, Inc, Genmab, Reata Pharmaceuticals
Antoine Italiano, MD, PhD
GRANTS RECEIVED
AstraZeneca, Bayer, Merck, Merck Sharp &
Dohme, PharmaMar, Roche
HONORARIA
Bayer, Daiichi Sankyo, Epizyme, Ipsen,
Roche, SpringWorks Therapeutics
Shivaani Kummar, MD, FACP
CONSULTANCIES OR PAID ADVISORY BOARDS
Bayer, Boehringer Ingelheim, EcoR1 Capital,
Genome & Company, Gilead, Harbour Biomed,
Seagen, SpringWorks Therapeutics, Mirati
Therapeutics, Mundipharma
STOCK OWNERSHIP
Cofounder and equity holder for PathomIQ
OTHER
Editor-in-chief of Current Problems in Cancer
(Elsevier); spouse is a scientific adviser
for Cadila Pharmaceuticals Ltd and founder
of Arxeon, Inc
Ulrik Lassen, MD, PhD
CONSULTANCIES OR PAID ADVISORY BOARDS
Bayer, Novartis, Pfizer
GRANTS RECEIVED
Bristol Myers Squibb, GlaxoSmithKline,
Pfizer, Roche
Sean D. Sullivan, PhD, MSc, RPh
CONSULTANCIES OR PAID ADVISORY BOARDS
Bayer
Signed disclosures are on file at the office of The American Journal of Managed Care®, Cranbury, New Jersey.